Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Novartis AG (NVS) had Cash Flow from Investing Activities of $5.60B for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$46.66B |
|
$14.85B |
|
$12.47B |
|
$34.19B |
|
$36.89B |
|
$9.77B |
|
$-646.00M |
|
$9.12B |
|
$9.12B |
|
$8.57B |
|
$8.57B |
|
$14.85B |
|
$8.57B |
|
$9.77B |
|
$18.15B |
|
2.08B |
|
2.09B |
|
$7.15 |
|
$7.10 |
|
Balance Sheet Financials | |
$30.48B |
|
$9.51B |
|
$69.46B |
|
$99.94B |
|
$26.39B |
|
$18.44B |
|
$26.80B |
|
$53.20B |
|
$46.75B |
|
$-3.47B |
|
$46.75B |
|
2.04B |
|
Cash Flow Statement Financials | |
$14.46B |
|
Cash Flow from Investing Activities |
$5.60B |
$-14.28B |
|
$7.52B |
|
$13.39B |
|
$5.88B |
|
$865.00M |
|
$-7.25B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.16 |
|
-- |
|
-- |
|
0.28 |
|
0.53 |
|
73.27% |
|
20.94% |
|
20.94% |
|
38.90% |
|
19.55% |
|
31.83% |
|
$13.63B |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
2.11 |
|
6.19 |
|
58.93 |
|
18.34% |
|
-247.03% |
|
8.58% |
|
13.15% |
|
$22.87 |
|
$6.52 |
|
$6.91 |